Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction by Pearson, Kevin J. et al.
Nrf2 mediates cancer protection but not prolongevity
induced by caloric restriction
Kevin J. Pearson*, Kaitlyn N. Lewis*, Nathan L. Price*, Joy W. Chang*, Evelyn Perez*, Maria Victoria Cascajo†,
Kellie L. Tamashiro‡, Suresh Poosala§, Anna Csiszar¶, Zoltan Ungvari¶, Thomas W. Kensler, Masayuki Yamamoto**,
Josephine M. Egan††, Dan L. Longo‡‡, Donald K. Ingram*§§, Placido Navas†, and Rafael de Cabo*¶¶
Laboratories of *Experimental Gerontology, ††Clinical Investigation, and ‡‡Immunology and §Research Resources Branch, National Institute on Aging,
National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224; †Centro Andaluz de Biologı´a del Desarrollo, Universidad Pablo de
Olavide-Consejo Superior de Investigaciones Cientı´ficas, and El Centro de Investigacio´n Biome´dica en Red de Enfermedades Raras, Instituto de Salud Carlos
III, Carretera de Utrera km 1, 41013 Seville, Spain; ‡Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine,
Baltimore, MD 21205; ¶Department of Physiology, New York Medical College, Valhalla, NY 10595; Department of Environmental Health Sciences,
Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21202; **Center for Tsukuka Advanced Research Alliance, University of
Tsukuba, 1-1-1 Tennoudai, Tsukuba 305-8577, Japan; and §§Nutritional Neuroscience and Aging Laboratory, Pennington Biomedical Research Center,
Louisiana State University System, 6400 Perkins Road, Baton Rouge, LA 70808
Communicated by Paul Talalay, Johns Hopkins University School of Medicine, Baltimore, MD, December 27, 2007 (received for review November 23, 2007)
Caloric restriction (CR) is the most potent intervention known to
both protect against carcinogenesis and extend lifespan in labo-
ratory animals. A variety of anticarcinogens and CR mimetics
induce and activate the NF-E2-related factor 2 (Nrf2) pathway.
Nrf2, in turn, induces a number of antioxidative and carcinogen-
detoxifying enzymes. Thus, Nrf2 offers a promising target for
anticarcinogenesis and antiaging interventions. We used Nrf2-
disrupted (KO) mice to examine its role on the biological effects of
CR. Here, we show that Nrf2 is responsible for most of the
anticarcinogenic effects of CR, but is dispensable for increased
insulin sensitivity and lifespan extension. Nrf2-deficient mice de-
veloped tumors more readily in response to carcinogen exposure
than did WT mice, and CR was ineffective in suppressing tumors in
the KO mice. However, CR extended lifespan and increased insulin
sensitivity similarly in KO and WT mice. These findings identify a
molecular pathway that dissociates the prolongevity and anticar-
cinogenic effects of CR.
aging  carcinogenesis  oxidative stress
A lmost a century ago, Moreschi (1) and Rous (2) publishedtheir observations on the beneficial impact of caloric re-
striction (CR) on transplanted and induced tumors. Years later,
McCay and colleagues first observed lifespan extension in lab-
oratory rats maintained on CR (3). Since then, CR has been
studied intensively with consistent results showing its beneficial
effects on longevity, age-associated diseases, attenuation of
functional decline, and carcinogenesis across a variety of species
and diet formulations (4–8). However, the mechanism(s) un-
derlying the effects of CR protection still remain unknown.
Nevertheless, it is safe to say that the three most extensively
studied hallmarks of CR are enhanced protection against in-
duced and spontaneous carcinogenesis, reduced insulin/insulin-
like growth factor 1 (IGF-1) signaling, and increased median and
maximum lifespan (5–9).
Even if CR was shown to benefit human health, confer cancer
protection, and increase longevity, it would be extremely difficult
to achieve adherence to such a stringent diet that might require
a reduction of 20–40% in caloric intake. To this end, consider-
able investment has been focused on dissecting the pathways that
regulate the beneficial effects of CR to spur development of
pharmacological agents potentially acting as CR mimetics (10).
Several of the currently proposed CR mimetics are phytochemi-
cals (resveratrol, quercetin, and curcumin) that act, at least in
part, through the activation of the NF-E2-related factor 2 (Nrf2)
pathway (11–14). Nrf2 is a transcription factor that binds to the
antioxidant response element (ARE) of target genes in response
to oxidative stress and increases the transcription of a variety of
antioxidative and carcinogen-detoxification enzymes. Stress can
result from a variety of causes, including fasting, overfeeding,
endogenous compounds, exposure to chemicals, or environmen-
tal agents, which generally leads to increased production of
reactive oxygen species (ROS). Under normal conditions, Nrf2
is bound to Keap1 in the cytoplasm, where it undergoes pro-
teolytic degradation and rapid turnover. However, upon ROS
exposure, Nrf2 is released and translocates to the nucleus, where
it binds to AREs to induce expression of multiple cytoprotective
enzymes, including NAD(P)H-quinone oxidoreductase 1
(NQO1), glutathione S-transferases (GSTs), and heme oxygen-
ase 1 (HO-1) (15, 16).
Nrf2 can be linked to each of the three hallmarks of CR:
protection against spontaneous and induced carcinogenesis, the
insulin/IGF-1 signaling pathway, and prolonged survival. A
variety of environmental carcinogens, including low levels of
UV-B irradiation, also activate Nrf2 and up-regulate ARE-
responsive gene products to enhance protection against cellular
and molecular damage that can induce cancer (17). In addition,
changes in insulin levels during fasting induce a mild oxidative
stress and an alteration of the expression of Nrf2-induced
enzymes (18).
Nrf2 expression has shown an age-related decrease in rodent
tissues (19, 20), possibly leading to higher levels of ROS and an
increased risk of cancer. However, CR has been shown to
attenuate the age-related loss of antioxidative capacity due to
aging and to increase levels of NQO1 and GST in brain and liver,
respectively (21–23). The lack of functional Nrf2 in mice in-
creases sensitivity to carcinogenesis through a lowered consti-
tutive expression of antioxidative and detoxifying enzymes in-
cluding NQO1 andGSTs (24–26). NQO1KOmice are also more
susceptible to chemical carcinogens as measured by a higher
incidence of tumors and more tumors per animal (26). They are
also insulin resistant, suggesting that NQO1 is involved in insulin
signaling (27). Addition of exogenous insulin to cells causes the
translocation of Nrf2 from the cytoplasm to the nucleus and
leads to increased expression of HO-1 and GSTs (28, 29).
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Mammalian cap ’n’ collar transcription factors, such as Nrf2,
are thought to be most closely related to the Caenorhabditis
elegans gene skn-1. SKN-1 is functionally similar to Nrf2 in that
it responds to oxidative stress and up-regulates detoxifying
enzymes (30, 31). In addition, overexpression of GSTs increases
median lifespan in C. elegans (32, 33), and skn-1 mutants have
shorter survival and reduced stress response compared with WT
worms (31, 34). The presence of skn-1 in only two neurons is
necessary for CR to increase median and maximum lifespan in
C. elegans (35). Because the regulation of lifespan appears
dependent on Nrf2-homologous pathways in C. elegans, the
survival effects of CR in mammals could be also regulated
through Nrf2 transcription factor networks. We hypothesized
that the advantageous effects of CR on carcinogenesis and
lifespan would require Nrf2. To explore the role of Nrf2 on
CR-mediated effects, KO mice were placed on ad libitum (AL)
and CR diets and were evaluated in a two-stage skin carcino-
genesis model, for insulin tolerance, and survival.
Results and Discussion
CR Induces Nrf2 Downstream Effectors. To explore the activation of
Nrf2 by CR, mRNA levels of several downstream effectors were
measured in AL- and CR-fed WT and KO mice. NQO1 mRNA
levels were significantly increased by CR inWT livers (P 0.05).
However, CR produced a small increase in NQO1 levels in KO
mice, but this increase was not statistically significant (Fig. 1A).
There were trends in the same direction for HO-1, glutamate-
cysteine ligase, catalytic subunit (GCLC), GST A1, and gluta-
thione peroxidase-1 (GPx-1), but they did not reach significance
when comparing AL to CR WT livers [supporting information
(SI) Fig. 5 A and D]. There were no trends toward increased
mRNA expression in the AL- vs. CR-fed KO mouse livers,
suggesting that these genes are not inducible under CR condi-
tions without activation of Nrf2. To ascertain the increases on
NQO1, we performed activity assays, which correlated well with
the differences seen in NQO1 mRNA levels (Fig. 1B). NQO1
activity was significantly increased in CR-fed WT and KO liver
cytosol compared with AL-fed WT and KO mice, respectively
(P 0.001 in both comparisons). In agreement with our findings,
CR attenuated the age-related loss of antioxidative capacity due
to aging and increased levels of NQO1 and GST in brain and
liver, respectively (21–23).
CR Requires Nrf2 for Protection Against Induced Tumors. Mice were
treated topically once with the tumor initiator 7,12-dimethyl-
benz(a)anthracene (DMBA) and then twice weekly with topical
treatments of the tumor promoter 12-O-tetradecanoyl phorbol-
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Fig. 2. Lack of protection against induced tumors in CR KO mice. (A) Forty
percent CR WT, 40% CR KO. (B) Thirty percent CR WT, 30% CR KO. (C) Twenty
percent CR WT, 20% CR KO. Shown are the percentages of mice with at least
one papilloma for AL and 40% CR-fed WT and KO (A) AL and 30% CR-fed WT
and KO (B) and AL and 20% CR-fed WT and KO (C) mice presenting tumors
after DMBA treatment at time 0. Black, AL WT; red, CR WT (20, 30, or 40%
restriction); green, AL KO; blue, CR KO (20, 30, or 40% restriction).
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Fig. 1. NQO1 levels are increased in response to CR. (A) Relative RNA levels
of NQO1 were determined by real-time PCR. Liver homogenates from AL and
40% CR-fed WT and KO mice were tested. CR significantly increased NQO1
levels in WT mice (P0.05), and there was a trend toward an increase in CR-fed
KO livers compared with AL-fed KO mice (P  0.07). n  3 for all groups. (B)
NQO1 activity was determined and CR-fed WT liver homogenates showed
increased activity compared with AL (P 0.001). Also, there was a significant
increase in the CR-fed KO mice compared with the AL-fed KO (P 0.001). n
5 for all groups. Black, AL WT; red, CR WT; green, AL KO; blue, CR KO.
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13-acetate (TPA) (SI Fig. 6A). DMBA has been shown to bind
to DNA and cause mutations particularly in the H-ras gene,
which is normally involved with proliferation and differentiation
(36). The tumor promoter TPA triggers ROS production and
causes hyperplasia in skin cells withH-rasmutations, which leads
ultimately to the formation of papillomas (36, 37). CR is
protective against the promotion phase of the two-stage carci-
nogenesis model and decreases tumor incidence and multiplicity
(38). A typical papilloma is an overgrowth of keratinocytes and
stromal cells (SI Fig. 6B). TPA treatment was terminated after
a single papilloma1 mm2 was observed on the mouse, because
initial tumor incidence was the main focus of this study. Rep-
resentative tumors were fixed and H&E stained (SI Fig. 6C).
Male WT, heterozygous (HT), and KO mice were maintained
on a standard diet. They were separated into AL and 40% CR
groups at 10 weeks of age. CR food weights were determined by
AL food intake and adjusted weekly to meet 40% of the AL
intake (of their respective genotype). Body weights dropped
markedly in the first 5 weeks after restriction in CR-fed WT and
KO mice (SI Fig. 7A). After body weights stabilized on the CR
diet, DMBAwas administered at time 0, and TPAwas then given
topically twice weekly beginning in week 2 until an initial tumor
was observed. AL-fed KO mice were more susceptible to
two-stage carcinogenesis than the AL-fed WT mice, corrobo-
rating data published in refs. 25 and 39. AL-fed KOmice showed
very rapid onset of tumorigenesis; both AL- and CR-fed KO
mice reached 100% tumor incidence by 30 weeks (Fig. 2A).
Tumor incidence in AL-fed WT mice was similar to that of the
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Fig. 3. Caloric restriction improves insulin sensitivity in WT and KO mice. (A) WT and KO mice were fed AL or 40% CR for 4 weeks. They were fasted overnight
(16 h), and glucose levels were determined. There was a trend toward a decrease in the CR-fed WT mice (P  0.09) and a significant decrease in the CR-fed KO
mice (P  0.01) compared with their respective AL-fed control mice. n  10 for all groups except CR-fed WT, for which n  9. (B) Fasting insulin values were
determined by ELISA. There was a trend toward a decrease in the CR-fed WT mice (P 0.10) and a significant decrease in the CR-fed KO mice (P 0.05) compared
with their respective AL-fed control mice.n 5 for all groups except CR-fed WT, for whichn 4. (C) HOMA values were calculated from fasted glucose and insulin
values, using the HOMA2 software available from the Oxford Centre for Diabetes, Endocrinology, and Metabolism Diabetes Trials Unit (www.dtu.ox.ac.uk). The
values were from five mice per group (except CR-fed WT, n 4) after a 16-h fast. There was a significant decrease in the HOMA values for CR vs. AL-fed KO mice
(P 0.01). (D) Fasting corticosterone levels. Corticosterone levels were significantly increased in CR-fed WT and KO mice compared with AL-fed WT and KO mice
respectively (P 0.01 in both cases). These mice were fed CR for 8 weeks. n 9 for all groups except AL-fed WT, for which n 7. Black, AL WT; red, CR WT; green,
AL KO; blue, CR KO.
Table 1. Tumor incidence by percentage of mice with at least one tumor, reported in weeks
Tumor
incidence, %
AL 20% CR 30% CR 40% CR
WT* HT KO* WT KO WT KO WT HT KO
10 10 7 7 10 9 11 10 n/a 18 17
25 13 7 8 18 10 18 11 n/a 20 21
50 15 8 9 n/a 11 20 12 n/a n/a 21
75 16 9 9 n/a 11 n/a 15 n/a n/a 23
90 24 9 10 n/a 13 n/a 17 n/a n/a 24
100 n/a 9 11 n/a 13 n/a 17 n/a n/a 30
n/a indicates that tumor incidence did not reach this percentage during study.
*Results averaged between two studies.
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CR-fed KO mice. Regarding tumor incidence in CR-fed WT
mice, the results were striking. In contrast to the CR-fed KO
mice, even at the end of the study with 42 weeks of treatment,
no papillomas were present in the CR-fed WT mice. Further
evidence of the importance of Nrf2 activation by CR is shown by
heterozygous mice that had intermediate tumor incidence when
compared with the WT and KO mice (SI Fig. 8 A and B).
Tumor incidence in the CR-fed KO mice was not significantly
different from the AL-fed WT mice under stringent conditions
of 40% CR. However, given the slight delay in onset of carci-
nogenesis, we investigated less-harsh CR conditions at 20% and
30% restriction in WT and KO mice. The body weights of the
20% and 30% CR-fed mice (SI Fig. 7 B and C) were decreased
when compared with the AL-fed mice. The incidence of tumors
in the 20% CR KO mice was not significantly different from the
AL-fed KO mice, and both groups were more susceptible than
the AL-fedWTmice to carcinogenesis (Fig. 2C). Meanwhile, the
30% CR-fed KO mice overlapped the AL-fed WT mice for the
duration of the study (Fig. 2B). The 20% and 30% CR-fed WT
mice were still significantly delayed in their development of
tumors compared with the AL-fed WT mice (Fig. 2 B and C).
The tumor onset results are also summarized in Table 1. Tumor
multiplicity was decreased in CR-fed KO mice compared with
AL-fed KO mice, but there were no significant differences
between the CR-fed KO mice and the AL-fed WT mice (SI Fig.
8C). The number of tumors per mouse was divided by the
number of weeks tumor development continued (from time of
first tumor) until the animal was euthanized to obtain a tumor
occurrence rate. Therefore, the anticarcinogenic effects of CR
are significantly impaired in Nrf2 KO mice. This impairment in
chemical-induced carcinogenesis was also observed in female
mice (SI Fig. 9 A and C).
CR Does Not Require Nrf2 for Insulin Sensitivity or Increased Longev-
ity. We next tested whether the delay of onset in tumorigenesis
was correlated with CR-induced changes in serum levels of
glucose, insulin, and IGF-1, which have been associated previ-
ously with tumor incidence. In another cohort of mice on CR for
4 weeks, WT mice had higher levels of fasting glucose than KO
mice. In both WT and KO mice, CR decreased glucose and
insulin levels (Fig. 3 A and B) and improved insulin sensitivity,
as measured by the homeostasis model assessment (HOMA)
method (Fig. 3C). Although these trends were consistent after a
4-week treatment among all groups involved in this study, the
changes reached statistical significance only for the KOmice.We
performed an insulin tolerance test in which glucose was mea-
sured after an i.p. insulin challenge. Glucose levels normally fall
in response to insulin and at a critical level of glucose, counter-
regulatory mechanisms are activated that increase glucose levels
(gluconeogenesis under the control of epinephrine and gluca-
gon, mainly). CR mice did not change their initial response to
insulin but both CR groups induced similar levels of counter-
regulatory activity in response to insulin-induced hypoglycemia
in both the WT and KO mice (data not shown). Fasting IGF-1
levels were also measured in serum frommice on CR for 4 weeks
(data not shown). There were no significant differences between
the AL and CR-fed mice of either genotype; thus, it is likely that
4 weeks of CR may not have been sufficient time to observe the
predicted decrease in IGF-1 levels. The adrenal gland and
particularly corticosterone levels have been shown to be impor-
tant factors in the development of induced tumors (40). Corti-
costerone was increased in CR-fed mice of both genotypes
compared with AL-fed mice (Fig. 3D). Thus, it is possible that
some of the delay in tumor development in the CR-fed KO mice
may be due to higher levels of corticosterone observed in these
mice.
Thus, the beneficial effects of CR on carcinogenesis appear
blunted in the absence of Nrf2, but improvement in insulin
sensitivity is maintained. We also set out to determine whether
this lack of protection by CR was also observed when using
longevity as the endpoint. For this study, we did not assess the
effects of CR on WT mice, because it would be fully expected
that CR would increase lifespan under these conditions as shown
by others (41). Rather, we focused on the important question of
whether the absence of Nrf2 would mitigate the effects of CR.
Male KO mice were split into AL-fed and 40% CR-fed groups
for a survival study at 20 weeks of age. The body weights of
CR-fed mice dropped over a 5–10 week period (Fig. 4A). AL-fed
mice maintained steady body weight until approximately week
90, when their weights began to decrease and eventually inter-
sected with the CR groups (data not shown). The survival curves
show that the CR and AL-fed KO mice overlapped until week
80, when they sharply diverged for the remainder of the study
with mice on a CR-fed diet surviving longer than mice on an
AL-fed diet (Fig. 4B). According to Kaplan–Meier analysis, the
survival curves for the AL and CRKOmice differed significantly
by the logrank test (2 28.9, P 0.0001). CR increased median
lifespan by 35.8% (144 vs. 106 weeks). Although maximum
lifespan has not yet been recorded in the CR KO group, it would
appear that it is certain to be extended. At this point, none of the
AL-fed Nrf2 mice are alive, and if the remainder of the CR-fed
mice (n  11) die within the next week, maximum lifespan will
have been significantly extended by 15% at a minimum. In-
creased median and maximum lifespan were also observed in
female mice (SI Fig. 9 B and D).
Conclusion
In this study, we have shown that the protective effects of CR
against carcinogenesis depend on a pathway that involves Nrf2.
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Fig. 4. Kaplan–Meier survival analyses for KO mice. (A) Body weight of male
mice in grams. KO mice were separated into two groups, AL and CR. The food
was gradually restricted to 40% less than that of the AL-fed KO mice. (B)
Kaplan–Meier survival analyses of AL and CR-fed KO mice were performed.
n 30 and n 32 for AL and CR-fed mice, respectively. The survival curves for
the AL and CR-fed KO mice differ significantly by the logrank test; ( 2 28.9,
P  0.0001). Green, AL KO; blue, CR KO.
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However, the lack of Nrf2 did not attenuate lifespan extension
nor alter the CR-induced improvement in insulin sensitivity in
the KO mice. A disconnect between tumor burden and lifespan
was also observed by Van Remmen et al. (42) when they showed
that reduction of an antioxidant enzyme couldmarkedly increase
DNA damage and spontaneous cancer incidence without affect-
ing survival and lifespan in AL-fed mice. However, our study
demonstrates that distinct pathways are involved in the various
beneficial effects of CR and suggests that many mechanisms are
involved in its protection. Recent data from invertebrates sug-
gested that Nrf2 or at least some of its downstream effectors
could hold the key to caloric restriction and longevity. It appears
now in mammals that besides the involvement of Nrf2 on
anticarcinogenic protection by CR, there must be other pathways
or factors regulating longevity. Our data suggest that the lifespan
extension seen in CR mice is not solely a consequence of
up-regulation of the Nrf2 pathway. Finally, and most impor-
tantly, the activation of the Nrf2 pathway is a promising target
to evaluate for CR mimetics in the search for preventive
strategies against environmentally-induced cancers.
Materials and Methods
Animals. Survival study. Nrf2 KO mice on an Institute of Cancer Research (ICR)
background were obtained from a colony at The Johns Hopkins University
and rederived at the National Institutes of Health (Bethesda, MD). They
were then bred to ICR mice (Taconic, Germantown, NY) from KO to WT and
then from HT to HO as described by Itoh et al. (43) in a specific pathogen-
free (SPF) facility at the National Institute on Aging and genotyped. Male
mice were maintained on NIH-31 diet until 20 weeks of age. Mice were then
randomly assigned to AL or CR groups with no initial differences in body
weights. CR mice were fed 40% less than AL-fed mice until the first 25% of
the AL mice were dead or stopped feeding normally. At this point, total
grams of food for CR mice were kept unchanged or the restriction was
adjusted to maintain the initial body weight differences. The mice were
singly housed in duplex caging in an environmentally-controlled vivariam
with unlimited access to water and a controlled photoperiod (12 h light;
12 h dark). Body weight and food intake data were recorded biweekly. All
mice were maintained between 68 and 72°F according to animal protocols
and National Institutes of Health guidelines. Survival curves were plotted
by using the Kaplan–Meier method in the MedCalc Program for Windows,
Version 9.2.1.0 (MedCalc Software). All mice were included in the survival
analysis (n  30 for AL and n  32 for CR mice). Survival studies were
performed in female mice following the same protocol as for the male mice
(n  30 for AL and n  30 for CR mice).
Induced carcinogenesis. Male ICR WT mice were purchased from Taconic, and
Nrf2 HT and KO mice were bred in the SPF colony at the National Institute on
Aging and were genotyped according to standard methods. The mice were
then transferred to a conventional animal facility. They were maintained on
Teklad 2018 diet under either AL or CR-fed conditions from 10 weeks of age.
Food intake and body weight data were measured weekly for the duration of
the study. CR food intake was calculated from AL food consumption for each
genotype. All mice were singly housed. All mice were maintained on a 12 h
light/12 h dark cycle and between 68 and 72°F according to animal protocols
and National Institutes of Health guidelines. After 5–6 weeks of CR, mice
began the two-stage carcinogenesis model. Induced carcinogenesis studies
were performed in female mice following the same protocol as for the male
mice.
Insulin sensitivity. Male ICR WT mice were purchased from Taconic, and KO
mice were bred and maintained under similar conditions to the induced
carcinogenesis study above. When they were 10 weeks of age, the mice were
fed either AL or 40% CR for 4 weeks before being used for the glucose and
insulin assays discussed in detail in SI Text. All diets contained 18–19% protein
and 5–6% fat.
Real-Time PCR. RNA was isolated from frozen liver sections of WT and KO mice
on AL and 40% CR diets from the two-stage carcinogenesis mice for NQO1 (n
3) or untreated mice for HO-1, GPx-1, GST A1, and GCLC (n  4–5 for each
group). Further details are provided in SI Text.
NQO1Activity Assay.NQO1 activity was measured in frozen liver homogenates
of 16-week-old WT and KO mice on AL and 40% CR diets for 6 weeks (n  5
for each group) as described in SI Text.
Two-Stage Carcinogenesis. Male mice were divided into groups according to
genotype. All groups began with an n  10, except for KO on 20 and 30%
restriction, wheren 15. Several mice were euthanized or found dead during
the study, and their data were included until the time when survival recording
was terminated. Mice on the CR-fed diet were restricted for 5–6 weeks until
body weights reflected the accurate restriction before tumor induction.
Within 24 h before DMBA tumor initiation, a 2 cm 2 cm area was shaved into
the dorsal fur. All mice were treated with a single dose of 25 g of DMBA
dissolved in 100 l of acetone. Because of the carcinogenicity of DMBA, the
mice were not handled for the following 72 h, at which time the cages and
bedding were changed. Tumor promotion with TPA (4 g dissolved in 100 l
of acetone) treatment began 2 weeks after DMBA initiation and continued
twice weekly until at least 1 papilloma with a radius1 mm was recorded for
tumor incidence data. The second week of TPA treatment was withheld
because of skin reactions on the mice. Individual mice were euthanized upon
the following criteria: tumor radius exceeded 1 cm or tumor(s) appeared to be
causing discomfort to the mouse. The majority of study groups were eutha-
nized when the tumor incidence exceeded 75% of the mice in a particular
group. Upon euthanasia, final tumor number, size, and total weight were
measured. Livers were collected and flash frozen in liquid nitrogen and stored
at 80°C.
SerumMarkers and Hormones.Details are provided in Fig. 3 legend and SI Text.
Statistics.Unpaired t tests were performed to compare AL and CR results from
a given genotype, using the StatView program. Statistics for the tumor
incidence were performed by taking the mean of the initial tumor incidence
week for each mouse. If a mouse did not develop a tumor throughout the
study, its value was designated as the week of sacrifice. Survival analysis was
performed with MedCalc statistical software.
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